
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Topiramate | FAERS: 8 | US FAERS | |
| 2 | Alendronate | FAERS: 5 | US FAERS | |
| 3 | Pantoprazole | FAERS: 3 | US FAERS | |
| 4 | Cyclosporine | FAERS: 2 | US FAERS | |
| 5 | Eplerenone | FAERS: 2 | OFFSIDES US FAERS | |
| 6 | Finasteride | FAERS: 2 | US FAERS | |
| 7 | Hydrochlorothiazide | FAERS: 2 | 17928827 | CTD US FAERS |
| 8 | Mycophenolic Acid | FAERS: 2 | US FAERS | |
| 9 | Norgestrel | FAERS: 2 | US FAERS | |
| 10 | Pregabalin | FAERS: 2 | US FAERS | |
| 11 | Spironolactone | FAERS: 2 | CTD US FAERS | |
| 12 | rofecoxib | FAERS: 2 | OFFSIDES US FAERS | |
| 13 | Amlodipine | FAERS: 1 | US FAERS | |
| 14 | Digoxin | FAERS: 1 | US FAERS | |
| 15 | Fentanyl | FAERS: 1 | US FAERS | |
| 16 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 17 | Indapamide | FAERS: 1 | US FAERS | |
| 18 | Methylprednisolone Hemisuccinate | FAERS: 1 | US FAERS | |
| 19 | NuvaRing | FAERS: 1 | US FAERS | |
| 20 | Octreotide | FAERS: 1 | US FAERS | |
| 21 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 22 | Thyroxine | FAERS: 1 | US FAERS | |
| 23 | Valproic Acid | FAERS: 1 | US FAERS | |
| 24 | Aldosterone | 6645193 | CTD | |
| 25 | Bendroflumethiazide | 20009770 | CTD | |
| 26 | Chlorthalidone | 1103606 | CTD | |
| 27 | Dexamethasone | CTD | ||
| 28 | Didanosine | OFFSIDES | ||
| 29 | Dyphylline | OFFSIDES | ||
| 30 | Fenofibrate | OFFSIDES | ||
| 31 | Furosemide | 6387403 | CTD | |
| 32 | Gentamicins | 5489186 | CTD | |
| 33 | Nevirapine | OFFSIDES | ||
| 34 | Nitrendipine | OFFSIDES | ||
| 35 | Pentamidine | OFFSIDES | ||
| 36 | Phosphates | OFFSIDES | ||
| 37 | Saquinavir | OFFSIDES | ||
| 38 | Streptozocin | 2819817 | CTD | |
| 39 | Tamoxifen | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.